Addex Therapeutics Ltd
Biotechnology
Healthcare
ADXN
150 K shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
6.51
52 week high
11.58
high
6.51
52 week low
6.51
low
6.51
growth
-24.30 %
previous Close
6.51
P/E ratio
1
market cap
8.30 M
div yield
0
usd
Sep 2024
qoq
revenue
53.84 K
-77.08 %
net incoming
-1.53 M
50.44 %
eps
10.17 %
350.68 %
eps surprise
0.00 %
net profit margin
-2841.86 %
-1527.00 %
operating incoming
-622.20 K
21.05 %
net change in cash
-438.60 K
80.40 %
cash on hand
3.35 M
105.74 %
cost of revenue
0.00 %
top top